Literature DB >> 20347787

Atrial fibrillation in congestive heart failure.

Steven A Lubitz1, Emelia J Benjamin, Patrick T Ellinor.   

Abstract

Atrial fibrillation and congestive heart failure are morbid conditions that have common risk factors and frequently coexist. Each condition predisposes to the other, and the concomitant presence of the two identifies individuals at increased risk for mortality. Recent data have emerged that help elucidate the complex genetic and nongenetic pathophysiological mechanisms that contribute to the development of atrial fibrillation in individuals with congestive heart failure. Clinical trial results offer insights into the noninvasive prevention and management of these conditions, although newer technologies, such as catheter ablation for atrial fibrillation, have yet to be studied extensively in patients with congestive heart failure. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20347787      PMCID： PMC2895405          DOI： 10.1016/j.hfc.2009.11.001

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  138 in total

Review 1.  Pathophysiology and prevention of atrial fibrillation.

Authors:  M A Allessie; P A Boyden; A J Camm; A G Kléber; M J Lab; M J Legato; M R Rosen; P J Schwartz; P M Spooner; D R Van Wagoner ; A L Waldo
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

2.  The pitx2 homeobox protein is required early for endoderm formation and nodal signaling. .

Authors:  M Faucourt; E Houliston; L Besnardeau; D Kimelman; T Lepage
Journal:  Dev Biol       Date:  2001-01-15       Impact factor: 3.582

3.  Gadolinium decreases stretch-induced vulnerability to atrial fibrillation.

Authors:  F Bode; A Katchman; R L Woosley; M R Franz
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

4.  Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation.

Authors:  S A Chen; M H Hsieh; C T Tai; C F Tsai; V S Prakash; W C Yu; T L Hsu; Y A Ding; M S Chang
Journal:  Circulation       Date:  1999-11-02       Impact factor: 29.690

5.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

6.  Incidence and aetiology of heart failure; a population-based study.

Authors:  M R Cowie; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; V Suresh; G C Sutton
Journal:  Eur Heart J       Date:  1999-03       Impact factor: 29.983

7.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

Authors:  D Fatkin; C MacRae; T Sasaki; M R Wolff; M Porcu; M Frenneaux; J Atherton; H J Vidaillet; S Spudich; U De Girolami; J G Seidman; C Seidman; F Muntoni; G Müehle; W Johnson; B McDonough
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

8.  Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Authors:  S H Hohnloser; K H Kuck; J Lilienthal
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

9.  Effects of experimental heart failure on atrial cellular and ionic electrophysiology.

Authors:  D Li; P Melnyk; J Feng; Z Wang; K Petrecca; A Shrier; S Nattel
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

10.  Atrial L-type Ca2+ currents and human atrial fibrillation.

Authors:  D R Van Wagoner; A L Pond; M Lamorgese; S S Rossie; P M McCarthy; J M Nerbonne
Journal:  Circ Res       Date:  1999-09-03       Impact factor: 17.367
View more
  34 in total

Review 1.  Déjà vu in the theories of atrial fibrillation dynamics.

Authors:  José Jalife
Journal:  Cardiovasc Res       Date:  2010-11-19       Impact factor: 10.787

2.  Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank.

Authors:  Seung Hoan Choi; Sean J Jurgens; Lu-Chen Weng; James P Pirruccello; Carolina Roselli; Mark Chaffin; Christina J-Y Lee; Amelia W Hall; Amit V Khera; Kathryn L Lunetta; Steven A Lubitz; Patrick T Ellinor
Journal:  Circ Res       Date:  2019-11-06       Impact factor: 17.367

Review 3.  Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.

Authors:  Fahad Shaikh; Lachlan B Pasch; Phillip J Newton; Beata V Bajorek; Caleb Ferguson
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

4.  Atrial fibrillation in heart failure: The sword of Damocles revisited.

Authors:  Muhammad A Khan; Fozia Ahmed; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2013-07-26

5.  Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure?

Authors:  Na Li; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-11       Impact factor: 3.000

6.  Evaluation of the effect of torsemide on warfarin dosage requirements.

Authors:  Sophia Lai; Jeremiah D Momper; Felix K Yam
Journal:  Int J Clin Pharm       Date:  2017-05-18

Review 7.  Ionic and substrate mechanism of atrial fibrillation: rotors and the exitación frequency approach.

Authors:  Omer Berenfeld
Journal:  Arch Cardiol Mex       Date:  2010 Oct-Dec

Review 8.  Patient-reported outcomes in heart failure: existing measures and future uses.

Authors:  Lauren E Thompson; David B Bekelman; Larry A Allen; Pamela N Peterson
Journal:  Curr Heart Fail Rep       Date:  2015-06

9.  Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia.

Authors:  Semira Abdi Beshir; Kok-Han Chee; Yoke-Lin Lo
Journal:  Int J Clin Pharm       Date:  2016-07-23

Review 10.  Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease.

Authors:  Nileshkumar J Patel; Aashay Patel; Kanishk Agnihotri; Dhaval Pau; Samir Patel; Badal Thakkar; Nikhil Nalluri; Deepak Asti; Ritesh Kanotra; Sabeeda Kadavath; Shilpkumar Arora; Nilay Patel; Achint Patel; Azfar Sheikh; Neil Patel; Apurva O Badheka; Abhishek Deshmukh; Hakan Paydak; Juan Viles-Gonzalez
Journal:  World J Cardiol       Date:  2015-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.